| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6846707
[patent_doc_number] => 20030165874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'KCNQ2 and KCNQ3 - potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies'
[patent_app_type] => new
[patent_app_number] => 10/096578
[patent_app_country] => US
[patent_app_date] => 2002-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 33309
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096578 | KCNQ2 and KCNQ3—potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies | Mar 13, 2002 | Issued |
Array
(
[id] => 6755308
[patent_doc_number] => 20030003085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Muscle-derived stem cells and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/097190
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12375
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097190
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097190 | Muscle-derived stem cells and uses therefor | Mar 12, 2002 | Abandoned |
Array
(
[id] => 5787082
[patent_doc_number] => 20020160403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'huBUB3 gene involved in human cancers'
[patent_app_type] => new
[patent_app_number] => 10/084700
[patent_app_country] => US
[patent_app_date] => 2002-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26469
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10084700
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/084700 | huBUB3 gene involved in human cancers | Feb 26, 2002 | Abandoned |
Array
(
[id] => 6642231
[patent_doc_number] => 20030103947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'In vitro engineered cartilage constructs produced by coating biodegradable polymer with human mesenchymal stem cells'
[patent_app_type] => new
[patent_app_number] => 10/082636
[patent_app_country] => US
[patent_app_date] => 2002-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5994
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10082636
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/082636 | In vitro engineered cartilage constructs produced by coating biodegradable polymer with human mesenchymal stem cells | Feb 24, 2002 | Abandoned |
Array
(
[id] => 7463773
[patent_doc_number] => 20040101526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Agents, which inhibit apoptosis in cells that are involved in wound healing'
[patent_app_type] => new
[patent_app_number] => 10/469126
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13533
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20040101526.pdf
[firstpage_image] =>[orig_patent_app_number] => 10469126
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/469126 | Agents, which inhibit apoptosis in cells that are involved in wound healing | Feb 20, 2002 | Issued |
Array
(
[id] => 527805
[patent_doc_number] => 07179447
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-02-20
[patent_title] => 'Type I interferon-producing cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/067146
[patent_app_country] => US
[patent_app_date] => 2002-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17901
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179447.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067146
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067146 | Type I interferon-producing cells and uses thereof | Feb 3, 2002 | Issued |
Array
(
[id] => 616645
[patent_doc_number] => 07145057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-05
[patent_title] => 'Chimeric bird from embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/067148
[patent_app_country] => US
[patent_app_date] => 2002-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 24
[patent_no_of_words] => 12197
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/145/07145057.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067148
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067148 | Chimeric bird from embryonic stem cells | Jan 31, 2002 | Issued |
| 09/936278 | Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) | Jan 23, 2002 | Abandoned |
Array
(
[id] => 6730216
[patent_doc_number] => 20030186406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide'
[patent_app_type] => new
[patent_app_number] => 10/038899
[patent_app_country] => US
[patent_app_date] => 2002-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6061
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186406.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038899
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038899 | Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide | Jan 7, 2002 | Abandoned |
Array
(
[id] => 5921037
[patent_doc_number] => 20020114783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Lentiviral vector-mediated gene transfer and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/025264
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 10341
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20020114783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10025264
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/025264 | Lentiviral vector-mediated gene transfer and uses thereof | Dec 18, 2001 | Abandoned |
Array
(
[id] => 6668926
[patent_doc_number] => 20030113910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Pluripotent stem cells derived without the use of embryos or fetal tissue'
[patent_app_type] => new
[patent_app_number] => 10/026420
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29245
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026420
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026420 | Pluripotent stem cells derived without the use of embryos or fetal tissue | Dec 18, 2001 | Abandoned |
Array
(
[id] => 6628629
[patent_doc_number] => 20020086409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Methods and compounds for modulating male fertility'
[patent_app_type] => new
[patent_app_number] => 10/024433
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14484
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024433 | Methods and compounds for modulating male fertility | Dec 17, 2001 | Issued |
| 10/009874 | Gene and protein sequences of phage t4 gene 35 | Dec 10, 2001 | Abandoned |
Array
(
[id] => 963550
[patent_doc_number] => 06949362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-27
[patent_title] => 'Rhodococcus cloning and expression vectors'
[patent_app_type] => utility
[patent_app_number] => 10/007527
[patent_app_country] => US
[patent_app_date] => 2001-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18153
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949362.pdf
[firstpage_image] =>[orig_patent_app_number] => 10007527
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/007527 | Rhodococcus cloning and expression vectors | Dec 4, 2001 | Issued |
Array
(
[id] => 6815134
[patent_doc_number] => 20030074684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Control of gene expression'
[patent_app_type] => new
[patent_app_number] => 09/997905
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 78
[patent_no_of_words] => 35429
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20030074684.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997905
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997905 | Control of gene expression | Nov 29, 2001 | Abandoned |
Array
(
[id] => 7469581
[patent_doc_number] => 20040054140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Numb protein expression inhibitor making use musashi'
[patent_app_type] => new
[patent_app_number] => 10/343311
[patent_app_country] => US
[patent_app_date] => 2003-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7975
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20040054140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343311 | Numb protein expression inhibitors by Musashi | Nov 21, 2001 | Issued |
Array
(
[id] => 6651282
[patent_doc_number] => 20030105039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'In vivo homologous sequence targeting in cells'
[patent_app_type] => new
[patent_app_number] => 09/990433
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 34075
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105039.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990433
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990433 | In vivo homologous sequence targeting in cells | Nov 19, 2001 | Abandoned |
Array
(
[id] => 6774215
[patent_doc_number] => 20030017553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Nucleotide sequences for transcriptional regulation in corynebacterium glutamicum'
[patent_app_type] => new
[patent_app_number] => 09/987763
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22322
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017553.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987763
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987763 | Nucleotide sequences for transcriptional regulation in corynebacterium glutamicum | Nov 14, 2001 | Issued |
Array
(
[id] => 6161773
[patent_doc_number] => 20020148000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'HS-40 enhancer-containing vector in transgenic animals'
[patent_app_type] => new
[patent_app_number] => 10/014220
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6495
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20020148000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014220 | HS-40 enhancer-containing vector in transgenic animals | Nov 8, 2001 | Abandoned |
| 09/868663 | Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same | Nov 4, 2001 | Abandoned |